PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel aptamer boosts T cell-based immune response to therapeutic vaccines

Novel aptamer boosts T cell-based immune response to therapeutic vaccines
2013-01-24
(Press-News.org) New Rochelle, NY, January 22, 2013—A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells. The development of a novel apatamer that recognizes activated T-lymphocytes and can boost the therapeutic effect of cell-based vaccines is described in an article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers (http://www.liebertpub.com). The article is available on the Nucleic Acid Therapeutics website (http://www.liebertpub.com/nat).

Elizabeth Pratico, Bruce Sullenger, and Smita Nair, Duke University Medical Center, Durham, NC, describe the innovative techniques they used to create an aptamer—a short sequence of nucleic acids—that binds to the human protein OX40, a costimulatory molecule present on the surface of already activated immune cells.

In the article "Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40," (http://online.liebertpub.com/doi/full/10.1089/nat.2012.0388) the researchers demonstrate that binding of the aptamer to OX40 on activated T cells enhances the cells' ability to proliferate and to produce the immunostimulatory cytokine interferon-gamma. The authors envision future studies that would evaluate the therapeutic potential of the human OX40 aptamer, which could be used to stimulate T cells during the production of patient-specific vaccines for use in cell therapy and personalized medicine.

"The therapeutic potential of aptamers has always been one of their most promising aspects," says Executive Editor Fintan Steele, PhD, SomaLogic, Inc., Boulder, CO. "This elegant work by the Duke team underlines that promise while extending it into the critical area of immunotherapy."

INFORMATION:

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).

About the Journal

Nucleic Acid Therapeutics (http://www.liebertpub.com/nat) is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the Official Journal of the Oligonucleotide Therapeutics Society (http://www.oligotherapeutics.org). Complete tables of content and a free sample issue may be viewed on the Nucleic Acid Therapeutics website (http://www.liebertpub.com/nat).

About the Publisher

Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy, Genetic Testing and Molecular Biomarkers, ASSAY and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. publishers website (http://www.liebertpub.com).

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101

[Attachments] See images for this press release:
Novel aptamer boosts T cell-based immune response to therapeutic vaccines

ELSE PRESS RELEASES FROM THIS DATE:

Microbiologists eavesdrop on the hidden lives of microbes

2013-01-24
(CAMBRIDGE, MA) -- Microbiologists who study wild marine microbes, as opposed to the lab-grown variety, face enormous challenges in getting a clear picture of the daily activities of their subjects. But a team of scientists from MIT and the Monterey Bay Aquarium Research Institute recently figured out how to make the equivalent of a nature film, showing the simultaneous activities of many coexisting species in their native habitat over time. Instead of making a movie, the scientists used a robotic device that dangled below the surface of the ocean, drifting in the water ...

Scientists identify new strategy to fight deadly infection in cystic fibrosis

2013-01-24
COLUMBUS, Ohio – New research suggests that lowering excessive levels of a protein in immune system cells could be a strategy to clear an infection that is deadly to patients with cystic fibrosis (CF). Researchers determined that normalizing levels of the protein, called p62, in cells from mice carrying the most common mutation that causes CF will jump-start a natural cellular process that clears away the offending bacteria. The scientists had previously determined that in cells from mice and humans carrying the CF mutation, the bacteria that cause this infection interfere ...

Health and environment: A closer look at plastics

Health and environment: A closer look at plastics
2013-01-24
Plastics have transformed modern society, providing attractive benefits but also befouling waterways and aquifers, depleting petroleum supplies and disrupting human health. Rolf Halden, a researcher at Arizona State University's Biodesign Institute has been following the chemical trail of plastics, quantifying their impact on human health and the environment. In a new overview appearing in the journal Reviews on Environmental Health, Halden and his co-author, ASU student Emily North, detail the risks and societal rewards of plastics and describe strategies to mitigate ...

Retrovirus in the human genome is active in pluripotent stem cells

2013-01-24
WORCESTER, MA – A retrovirus called HERV-H, which inserted itself into the human genome millions of years ago, may play an important role in pluripotent stem cells, according to a new study published in the journal Retrovirology by scientists at UMass Medical School. Pluripotent stem cells are capable of generating all tissue types, including blood cells, brain cells and heart cells. The discovery, which may help explain how these cells maintain a state of pluripotency and are able to differentiate into many types of cells, could have profound implications for therapies ...

Implementation of smoke-free legislation reduces the number of acute myocardial infarctions by 11 percent

2013-01-24
Researchers participating in the REGICOR Study (Girona Heart Registry), with the participation of IMIM (Hospital del Mar Medical Research Institute) from Barcelona, the Josep Trueta Hospital, the Blanes Hospital and IDIAP Jordi Gol from Girona (Primary Healthcare Research Institute) have carried out a study to assess the impact of the partial smoke-free legislation passed in 2006 on the incidence of acute myocardial infarction in the province of Girona and observed it has dropped 11%. This decrease has been noticed especially among women, population aged between 65 and ...

Oxygen chamber can boost brain repair

2013-01-24
Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success. Now Dr. Shai Efrati of Tel Aviv University's Sackler Faculty of Medicine has found a way to restore a significant amount of neurological function in brain tissue thought to be chronically damaged — even years after initial injury. Theorizing that high levels of oxygen could reinvigorate ...

Learning and memory may play a central role in synesthesia

2013-01-24
People with color-grapheme synesthesia experience color when viewing written letters or numerals, usually with a particular color evoked by each grapheme (i.e., the letter 'A' evokes the color red). In a new study, researchers Nathan Witthoft and Jonathan Winawer of Stanford University present data from 11 color grapheme synesthetes who had startlingly similar color-letter pairings that were traceable to childhood toys containing magnetic colored letters. Their findings are published in Psychological Science, a journal of the Association for Psychological Science. Matching ...

Household chores: Gender equality's final frontier

2013-01-24
ITHACA, N.Y. – Working-class couples that buck convention and live together rather than marry take on traditional roles when it comes to housework, according to a new study by a Cornell University sociologist. Cohabiting women do a disproportionate share of the housework, even when the women work and the men don't – and even when the women want to share the housework more equally, said co-author Sharon Sassler, Cornell professor of policy analysis and management. "When men aren't working, they don't see domestic labor as a means of contributing. In fact, they double ...

New research may aid treatment of multiple myeloma patients

2013-01-24
WASHINGTON (Jan. 23, 2013) – A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which patients with multiple myeloma will respond better to certain treatments. The study, titled "Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1," was published in the American Journal of Hematology and is available online at: ...

Space instrument adds big piece to the solar corona puzzle

Space instrument adds big piece to the solar corona puzzle
2013-01-24
The Sun's visible surface, or photosphere, is 10,000 degrees Fahrenheit. As you move outward from it, you pass through a tenuous layer of hot, ionized gas or plasma called the corona. The corona is familiar to anyone who has seen a total solar eclipse, since it glimmers ghostly white around the hidden Sun. But how can the solar atmosphere get hotter, rather than colder, the farther you go from the Sun's surface? This mystery has puzzled solar astronomers for decades. A suborbital rocket mission that launched in July 2012 has just provided a major piece of the puzzle. The ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Novel aptamer boosts T cell-based immune response to therapeutic vaccines